{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:25:27Z","timestamp":1790713527312,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.antiviral.2020.104972","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T22:18:40Z","timestamp":1606169920000},"page":"104972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Host RNA quality control as a hepatitis B antiviral target"],"prefix":"10.1016","volume":"186","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0343-7668","authenticated-orcid":false,"given":"Timothy M.","family":"Block","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1824-2561","authenticated-orcid":false,"given":"John A.T.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Javanbakht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Sofia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianlun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.antiviral.2020.104972_bib1","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/cmdc.202000011","article-title":"Small-molecule inhibitors of METTL3, the major human epitranscriptomic writer","volume":"15","author":"Bedi","year":"2020","journal-title":"ChemMedChem"},{"issue":"5","key":"10.1016\/j.antiviral.2020.104972_bib2","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1261\/rna.032292.112","article-title":"Maturation of mammalian H\/ACA box snoRNAs: PAPD5-dependent adenylation and PARN-dependent trimming","volume":"18","author":"Berndt","year":"2012","journal-title":"RNA"},{"issue":"9","key":"10.1016\/j.antiviral.2020.104972_bib3","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/cid\/cix129","article-title":"Use of current and new endpoints in the evaluation of experimental hepatitis B therapeutics","volume":"64","author":"Block","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104972_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2017.12.006","article-title":"Research priorities for the discovery of a cure for chronic hepatitis B: report of a workshop","volume":"150","author":"Block","year":"2018","journal-title":"Antivir. Res."},{"issue":"9","key":"10.1016\/j.antiviral.2020.104972_bib5","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1172\/JCI87547","article-title":"Posttranscriptional manipulation of TERC reverses molecular hallmarks of telomere disease","volume":"126","author":"Boyraz","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"7345","key":"10.1016\/j.antiviral.2020.104972_bib6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature09908","article-title":"CPEB and two poly(A) polymerases control miR-122 stability and p53 mRNA translation","volume":"473","author":"Burns","year":"2011","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.antiviral.2020.104972_bib7","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.cell.2007.10.041","article-title":"RNA quality control in eukaryotes","volume":"131","author":"Doma","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2020.104972_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41573-019-0037-0","article-title":"Therapeutic strategies for hepatitis B virus infection: towards a cure","author":"Fanning","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.antiviral.2020.104972_bib9","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1182\/blood-2018-11-885368","article-title":"Posttranscriptional modulation of TERC by PAPD5 inhibition rescues hematopoietic development in dyskeratosis congenita","volume":"133","author":"Fok","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2020.104972_bib10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1146\/annurev.bi.56.070187.003251","article-title":"The molecular biology of the hepatitis B viruses","volume":"56","author":"Ganem","year":"1987","journal-title":"Annu. Rev. Biochem."},{"issue":"5587","key":"10.1016\/j.antiviral.2020.104972_bib11","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1126\/science.1074276","article-title":"Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein","volume":"297","author":"Gao","year":"2002","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.antiviral.2020.104972_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cld.2019.04.001","article-title":"Global perspective on hepatitis B virus infections in the era of effective vaccines","volume":"23","author":"Gomes","year":"2019","journal-title":"Clin. Liver Dis."},{"issue":"34","key":"10.1016\/j.antiviral.2020.104972_bib13","doi-asserted-by":"crossref","first-page":"15045","DOI":"10.1073\/pnas.1003505107","article-title":"Structure and function of the polymerase core of TRAMP, a RNA surveillance complex","volume":"107","author":"Hamill","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.antiviral.2020.104972_bib14","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1128\/JVI.73.7.5767-5776.1999","article-title":"La autoantigen specifically recognizes a predicted stem-loop in hepatitis B virus RNA","volume":"73","author":"Heise","year":"1999","journal-title":"J. Virol."},{"issue":"15","key":"10.1016\/j.antiviral.2020.104972_bib15","doi-asserted-by":"crossref","first-page":"6874","DOI":"10.1128\/JVI.75.15.6874-6883.2001","article-title":"Characterization of nuclear RNases that cleave hepatitis B virus RNA near the La protein binding site","volume":"75","author":"Heise","year":"2001","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.antiviral.2020.104972_bib16","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/hep.21627","article-title":"Management of hepatitis B: summary of a clinical research workshop","volume":"45","author":"Hoofnagle","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.antiviral.2020.104972_bib17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.embor.7400612","article-title":"Yeast Trf5p is a nuclear poly(A) polymerase","volume":"7","author":"Houseley","year":"2006","journal-title":"EMBO Rep."},{"issue":"7","key":"10.1016\/j.antiviral.2020.104972_bib18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrm1964","article-title":"RNA-quality control by the exosome","volume":"7","author":"Houseley","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.antiviral.2020.104972_bib19","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1016\/j.celrep.2019.10.113","article-title":"A genome-wide CRISPR screen identifies ZCCHC14 as a host factor required for hepatitis B surface antigen production","volume":"29","author":"Hyrina","year":"2019","journal-title":"Cell Rep."},{"issue":"35","key":"10.1016\/j.antiviral.2020.104972_bib20","doi-asserted-by":"crossref","first-page":"8829","DOI":"10.1073\/pnas.1808319115","article-title":"N6-methyladenosine modification of hepatitis B virus RNA differentially regulates the viral life cycle","volume":"115","author":"Imam","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.antiviral.2020.104972_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008338","article-title":"Interferon-stimulated gene 20 (ISG20) selectively degrades N6-methyladenosine modified Hepatitis B Virus transcripts","volume":"16","author":"Imam","year":"2020","journal-title":"PLoS Pathog."},{"issue":"6","key":"10.1016\/j.antiviral.2020.104972_bib22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41594-020-0427-3","article-title":"Viral hijacking of the TENT4-ZCCHC14 complex protects viral RNAs via mixed tailing","volume":"27","author":"Kim","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.antiviral.2020.104972_bib23","article-title":"UFMylation and TRAMP-like complexes are required for hepatitis A virus pathogenesis","author":"Kulsuptrakul","year":"2019","journal-title":"bioRxiv"},{"issue":"12","key":"10.1016\/j.antiviral.2020.104972_bib24","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1016\/j.bbamcr.2016.09.023","article-title":"Cytoplasmic RNA decay pathways - enzymes and mechanisms","volume":"1863","author":"Labno","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.antiviral.2020.104972_bib25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cell.2005.04.029","article-title":"RNA degradation by the exosome is promoted by a nuclear polyadenylation complex","volume":"121","author":"LaCava","year":"2005","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.antiviral.2020.104972_bib26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41575-018-0041-6","article-title":"The hepatitis B epidemic and the urgent need for cure preparedness","volume":"15","author":"Lazarus","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.antiviral.2020.104972_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ceb.2005.03.002","article-title":"Mechanistic links between nonsense-mediated mRNA decay and pre-mRNA splicing in mammalian cells","volume":"17","author":"Lejeune","year":"2005","journal-title":"Curr. Opin. Cell Biol."},{"issue":"13","key":"10.1016\/j.antiviral.2020.104972_bib28","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1128\/JVI.00236-10","article-title":"Inhibition of hepatitis B virus replication by MyD88 involves accelerated degradation of pregenomic RNA and nuclear retention of pre-S\/S RNAs","volume":"84","author":"Li","year":"2010","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.antiviral.2020.104972_bib29","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/hep.28025","article-title":"Present and future therapies of hepatitis B: from discovery to cure","volume":"62","author":"Liang","year":"2015","journal-title":"Hepatology"},{"issue":"6403","key":"10.1016\/j.antiviral.2020.104972_bib30","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1126\/science.aam5794","article-title":"Mixed tailing by TENT4A and TENT4B shields mRNA from rapid deadenylation","volume":"361","author":"Lim","year":"2018","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.antiviral.2020.104972_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006296","article-title":"Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA","volume":"13","author":"Liu","year":"2017","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.antiviral.2020.104972_bib32","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.molcel.2011.06.028","article-title":"Interaction profiling identifies the human nuclear exosome targeting complex","volume":"43","author":"Lubas","year":"2011","journal-title":"Mol. Cell"},{"issue":"7","key":"10.1016\/j.antiviral.2020.104972_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003494","article-title":"Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein","volume":"9","author":"Mao","year":"2013","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.antiviral.2020.104972_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv359","article-title":"Hepatitis-associated liver cancer: gaps and opportunities to improve care","volume":"108","author":"McMahon","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"issue":"6","key":"10.1016\/j.antiviral.2020.104972_bib35","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/hep4.1502","article-title":"Efficacy of an inhibitor of hepatitis B virus expression in combination with entecavir and interferon-alpha in woodchucks chronically infected with Woodchuck hepatitis virus","volume":"4","author":"Menne","year":"2020","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.antiviral.2020.104972_bib36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.antiviral.2018.08.014","article-title":"Host functions used by hepatitis B virus to complete its life cycle: implications for developing host-targeting agents to treat chronic hepatitis B","volume":"158","author":"Mitra","year":"2018","journal-title":"Antivir. Res."},{"issue":"5","key":"10.1016\/j.antiviral.2020.104972_bib37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1365-2893.2002.00381.x","article-title":"Regulatory elements of hepatitis B virus transcription","volume":"9","author":"Moolla","year":"2002","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2020.104972_bib38","article-title":"PAPD5\/7 are novel host factors that are required for Hepatitis B virus RNA stabilization","author":"Mueller","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.antiviral.2020.104972_bib39","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2017.10.014","article-title":"A novel orally available small molecule that inhibits hepatitis B virus expression","volume":"68","author":"Mueller","year":"2018","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.antiviral.2020.104972_bib40","doi-asserted-by":"crossref","first-page":"334","DOI":"10.4161\/rna.19431","article-title":"Tri-snRNP-associated proteins interact with subunits of the TRAMP and nuclear exosome complexes, linking RNA decay and pre-mRNA splicing","volume":"9","author":"Nag","year":"2012","journal-title":"RNA Biol."},{"key":"10.1016\/j.antiviral.2020.104972_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2020.03.016","article-title":"Small-molecule PAPD5 inhibitors restore telomerase activity in patient stem cells","author":"Nagpal","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"12","key":"10.1016\/j.antiviral.2020.104972_bib42","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S1473-3099(16)30204-3","article-title":"Requirements for global elimination of hepatitis B: a modelling study","volume":"16","author":"Nayagam","year":"2016","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.antiviral.2020.104972_bib43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbrc.2013.01.072","article-title":"Molecular cloning and characterization of a novel isoform of the non-canonical poly(A) polymerase PAPD7","volume":"432","author":"Ogami","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.antiviral.2020.104972_bib44","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1128\/MCB.20.3.834-841.2000","article-title":"A composite polyadenylation signal with TATA box function","volume":"20","author":"Paran","year":"2000","journal-title":"Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.antiviral.2020.104972_bib45","doi-asserted-by":"crossref","first-page":"e1529","DOI":"10.1002\/wrna.1529","article-title":"Writing a wrong: coupled RNA polymerase II transcription and RNA quality control","volume":"10","author":"Peck","year":"2019","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"4","key":"10.1016\/j.antiviral.2020.104972_bib46","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0092-8674(02)00617-7","article-title":"Integrating mRNA processing with transcription","volume":"108","author":"Proudfoot","year":"2002","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.antiviral.2020.104972_bib47","first-page":"1766","article-title":"Transcription of hepatitis B virus by RNA polymerase II","volume":"3","author":"Rall","year":"1983","journal-title":"Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.antiviral.2020.104972_bib48","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1261\/rna.2787011","article-title":"PAPD5, a noncanonical poly(A) polymerase with an unusual RNA-binding motif","volume":"17","author":"Rammelt","year":"2011","journal-title":"RNA"},{"issue":"7","key":"10.1016\/j.antiviral.2020.104972_bib49","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S2468-1253(19)30119-0","article-title":"A global scientific strategy to cure hepatitis B","volume":"4","author":"Revill","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.antiviral.2020.104972_bib50","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1128\/mr.59.3.423-450.1995","article-title":"mRNA stability in mammalian cells","volume":"59","author":"Ross","year":"1995","journal-title":"Microbiol. Rev."},{"issue":"5","key":"10.1016\/j.antiviral.2020.104972_bib51","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1101\/gad.4.5.764","article-title":"Sequences 5' to the polyadenylation signal mediate differential poly(A) site use in hepatitis B viruses","volume":"4","author":"Russnak","year":"1990","journal-title":"Genes Dev."},{"issue":"8","key":"10.1016\/j.antiviral.2020.104972_bib52","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41576-018-0013-2","article-title":"Controlling nuclear RNA levels","volume":"19","author":"Schmid","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.antiviral.2020.104972_bib53","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-3-030-31434-7_4","article-title":"The nuclear RNA exosome and its cofactors","volume":"1203","author":"Schmid","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.antiviral.2020.104972_bib54","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/wrna.1155","article-title":"Nuclear RNA surveillance: role of TRAMP in controlling exosome specificity","volume":"4","author":"Schmidt","year":"2013","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"5","key":"10.1016\/j.antiviral.2020.104972_bib55","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/nar\/gkn006","article-title":"Solution structure of stem-loop alpha of the hepatitis B virus post-transcriptional regulatory element","volume":"36","author":"Schwalbe","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2020.104972_bib56","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","article-title":"Molecular biology of hepatitis B virus infection","volume":"479\u2013480","author":"Seeger","year":"2015","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.antiviral.2020.104972_bib57","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/embor.2009.271","article-title":"Polyadenylation and degradation of incomplete RNA polymerase I transcripts in mammalian cells","volume":"11","author":"Shcherbik","year":"2010","journal-title":"EMBO Rep."},{"issue":"11","key":"10.1016\/j.antiviral.2020.104972_bib58","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1093\/nar\/gkx239","article-title":"Essential role for non-canonical poly(A) polymerase GLD4 in cytoplasmic polyadenylation and carbohydrate metabolism","volume":"45","author":"Shin","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.antiviral.2020.104972_bib59","first-page":"2250","article-title":"Analysis of processing and polyadenylation signals of the hepatitis B virus surface antigen gene by using simian virus 40-hepatitis B virus chimeric plasmids","volume":"3","author":"Simonsen","year":"1983","journal-title":"Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.antiviral.2020.104972_bib60","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1074\/jbc.REV118.005594","article-title":"Polyadenylation and nuclear export of mRNAs","volume":"294","author":"Stewart","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.antiviral.2020.104972_bib61","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/wrna.52","article-title":"Cap and cap-binding proteins in the control of gene expression","volume":"2","author":"Topisirovic","year":"2011","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.antiviral.2020.104972_bib62","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.15078","article-title":"Magnitude of and prediction for risk of hepatocellular carcinoma in patients with chronic hepatitis B taking entecavir or tenofovir therapy: a systematic review","author":"Tseng","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1762","key":"10.1016\/j.antiviral.2020.104972_bib63","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2018.0169","article-title":"The multitasking polyA tail: nuclear RNA maturation, degradation and export","volume":"373","author":"Tudek","year":"2018","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"6","key":"10.1016\/j.antiviral.2020.104972_bib64","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1371\/journal.pbio.0030189","article-title":"A new yeast poly(A) polymerase complex involved in RNA quality control","volume":"3","author":"Vanacova","year":"2005","journal-title":"PLoS Biol."},{"issue":"5","key":"10.1016\/j.antiviral.2020.104972_bib65","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/gtc.12580","article-title":"MicroRNP-mediated translational activation of nonadenylated mRNAs in a mammalian cell-free system","volume":"23","author":"Wakiyama","year":"2018","journal-title":"Gene Cell."},{"key":"10.1016\/j.antiviral.2020.104972_bib66","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev-biochem-091719-064225","article-title":"RNA splicing by the spliceosome","volume":"89","author":"Wilkinson","year":"2020","journal-title":"Annu. Rev. Biochem."},{"issue":"5","key":"10.1016\/j.antiviral.2020.104972_bib67","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.cell.2005.04.030","article-title":"Cryptic pol II transcripts are degraded by a nuclear quality control pathway involving a new poly(A) polymerase","volume":"121","author":"Wyers","year":"2005","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.antiviral.2020.104972_bib68","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a032409","article-title":"Molecular mechanisms of pre-mRNA splicing through structural biology of the spliceosome","volume":"11","author":"Yan","year":"2019","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.antiviral.2020.104972_bib69","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.antiviral.2017.11.009","article-title":"HBsAg mRNA degradation induced by a dihydroquinolizinone compound depends on the HBV posttranscriptional regulatory element","volume":"149","author":"Zhou","year":"2018","journal-title":"Antivir. Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220303867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220303867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:34:27Z","timestamp":1759062867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354220303867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":69,"alternative-id":["S0166354220303867"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104972","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Host RNA quality control as a hepatitis B antiviral target","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104972","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104972"}}